On Invalid Date, Landos Biopharma (NASDAQ: LABP) reported Q1 2023 earnings per share (EPS) of -$0.90, up 75.68% year over year. Total Landos Biopharma earnings for the quarter were -$6.03 million. In the same quarter last year, Landos Biopharma's earnings per share (EPS) was -$3.70.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.